Print ISSN:-2394-2789

Online ISSN:-2394-2797

CODEN : IJPCN9

Current Issue

Year 2019

Volume: 6 , Issue: 4

Article view: 637

Article download: 180

International Journal of Pharmaceutical Chemistry and Analysis


Formulation and evaluation of lornoxicam emulgel


Full Text PDF Share on Facebook Share on Twitter


Author Details : Sonali P. Mahaparale, Vikas Gaware

Volume : 4, Issue : 3, Year : 2017

Article Page : 83-87


Suggest article by email

Abstract

Transdermal route of administration of drug is effective route of administration for different kind of indications. The purpose of present investigation was to develop Lornoxicam emulgel for systemic effect and to avoid side effects and minimize frequency of administration. Lornoxicam (NSAIDS) is a cox-1 and cox-2 inhibitor used in the treatment of pain, inflammations rheumatoid arthritis. Emulgel of lornoxicam was formulated using triethanolamine (5%) as solvent, carbopol 934 and carbopol 940 as gelling agents and various preservatives formulated gel was evaluated with respect to different physiochemical parameters such as ph, viscosity, Spreadability % drug content. All the prepared emulgel showed acceptable physical properties like homogeneity, colour, consistency, ph value, Grittiness, Spreadability, Extrudability % drug content. The results of in vitro drug release showed that carbopol 940 (0.4 gm) based emulgel gave better release. Also it was found that the gelling agent concentration had the most pronounced effect on the drug release from the emulgel.

Keywords: Lornoxicam, Carbopol, Hydroxyl Propyl methyl cellulose, Anti-inflammatory activity

How to cite : Mahaparale S P, Gaware V, Formulation and evaluation of lornoxicam emulgel. Int J Pharm Chem Anal 2017;4(3):83-87

Copyright © 2017 by author(s) and Int J Pharm Chem Anal. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0) (creativecommons.org)